ea0029p53 | Adrenal cortex | ICEECE2012
Han T.
, Stimson R.
, Rees A.
, Krone N.
, Willis D.
, Wild S.
, Conway G.
, Arlt W.
, Walker B.
, Ross R.
, CaHASE X.
We have previously reported the following metabolic abnormalities were common in 203 adult patients with CAH: obesity (41%), hypercholesterolemia (46%), insulin resistance (29%), osteopenia (40%) and osteoporosis (7%) (Arlt et al. JCEM 2010 95 511021). The CAH patients were taking different glucocorticoid therapies at various doses (n=196): hydrocortisone (n=25 M, 26 W), prednisolone (n=21M,67W), dexamethasone (n=15M,22W) or comb...